MiCo Pharma-B Surges Over 60% in Grey Market Trading, Earning HK$2,200 Per Lot
0xBroomberg
Maikejia Pharma-B is trading at HK$29.20 in the grey market, up 60.44% from its IPO price of HK$18.20 — each lot shows a paper gain of roughly HK$2,200, but the real test comes when the stock officially lists.
How big is the grey-market pop?
Maikejia Pharma-B (02335) is set to list on the HKEX on June 24; grey-market trading is active ahead of debut.
Livermore Securities quotes the stock at HK$29.20, a 60.44% premium to the IPO price of HK$18.20.
This means → buyers in the pre-listing market have priced the stock far above issuance, signaling strong short-term hype.
What does one lot earn on paper?
At 200 shares per lot, the grey-market price implies a paper gain of roughly HK$2,200 before fees.
In plain terms = an investor who landed one lot in the IPO is already sitting on a four-figure profit — on paper — before the bell rings.
Can the grey-market price hold?
Whether this premium survives the official first trading day is the key test of real market demand.
This means → grey-market gains reflect a thin pool of participants; once formal trading opens, liquidity and the number of sellers change completely, and the price may swing sharply.
For IPO subscribers, opening-day price and volume are the signals that will confirm — or deflate — this rally.
Content is for reference only, not financial advice.